Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

NCT00362479 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1347
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Duramed Research